The Food and Drug Administration says it has decided to continue approving COVID-19 vaccine updates for seniors and others at higher risk of severe disease, but will require vaccine makers to conduct major new clinical trials before approving them for wider use.

Under the new approach, updated Covid-19 vaccines are likely to be available this autumn only for people aged 65 and older, and for those over 6 months old who have conditions such as diabetes, asthma,